Dr. Adam M. Forman
Claim this profileAscension Providence Hospitals - Southfield
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
25 reported clinical trials
46 drugs studied
About Adam M. Forman
Education:
- Graduated with a Doctor of Medicine (MD) from Wayne State University School of Medicine.
- Completed Residency in Internal Medicine at St. John Hospital and Medical Center.
- Undertook a Fellowship in Gastroenterology at Henry Ford Hospital.
Experience:
- Currently practices as a gastroenterologist at Ascension Providence Hospitals - Southfield.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Adam M. Forman is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
More about Adam M. Forman
Clinical Trial Related4 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 16 Active Clinical TrialsTreatments Adam M. Forman has experience with
- Atezolizumab
- Pembrolizumab
- Carboplatin
- Nivolumab
- Lenalidomide
- Durvalumab
Breakdown of trials Adam M. Forman has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam M. Forman specialize in?
Adam M. Forman focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Adam M. Forman currently recruiting for clinical trials?
Yes, Adam M. Forman is currently recruiting for 15 clinical trials in Southfield Michigan. If you're interested in participating, you should apply.
Are there any treatments that Adam M. Forman has studied deeply?
Yes, Adam M. Forman has studied treatments such as Atezolizumab, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Adam M. Forman?
Apply for one of the trials that Adam M. Forman is conducting.
What is the office address of Adam M. Forman?
The office of Adam M. Forman is located at: Ascension Providence Hospitals - Southfield, Southfield, Michigan 48075 United States. This is the address for their practice at the Ascension Providence Hospitals - Southfield.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.